معرفی و مروری بر مدل سازی و پیش بینی میزان سمیت مواد شیمیایی بر اساس مدل های فارماکوکینیتک مبتنی بر فیزیولوژی با استفاده از نرم افزارهای کامپیوتری

Publish Year: 1402
نوع سند: مقاله ژورنالی
زبان: Persian
View: 171

This Paper With 12 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_HSR-19-3_001

تاریخ نمایه سازی: 30 شهریور 1402

Abstract:

امروزه کاربرد مدل های کینیتک مبتنی بر فیزیولوژی در مدل سازی و پیش بینی میزان سمیت مواد شیمیایی به سرعت در حال توسعه است. داده های مستخرج از این مدل ها علاوه بر کاربرد در ارزیابی خطر زیست محیطی، به طور گسترده ای در صنایع مختلف و بخش های تحقیقاتی مانند توسعه دارویی، ارزیابی ایمنی محصول و اقدامات بالینی یا دارویی به کار گرفته می شوند. همچنین، این مدل ها جایگزین مناسبی برای مدل های حیوانی محسوب می گردند. با پیشرفت علوم کامپیوتر، نرم افزارهای متعددی به منظور مدل سازی و درک بهتر این مدل ها طراحی شده است. هر کدام از این نرم افزارها دارای ویژگی های کاربری خاص خود می باشند و بسته به نیاز کاربر، قابلیت هایی را در مدل سازی ارایه می کنند. در پژوهش حاضر، تعدادی نرم افزار که مدل سازی را بر اساس مدل های فارماکوکنتیک مبتنی بر  فیزیولوژی (Physiologically based pharmacokinetic یا PBPK) انجام می دهند، معرفی و مزایا و معایب هرکدام از آن ها بیان گردید.

Authors

سارا کریمی زوردگانی

Associate Professor, Department of Occupational Health Engineering, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran

سید مهدی موسوی

PhD Student, Student Research Committee AND Department of Occupational Health Engineering, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran

مجتبی نخعی پور

PhD Student, Student Research Committee AND Department of Occupational Health Engineering, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran

حسین ابراهیمی

PhD Student, Student Research Committee AND Department of Occupational Health Engineering, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Yilmaz B, Terekeci H, Sandal S, Kelestimur F. Endocrine disrupting ...
  • Timbrell J, Barile FA. Introduction to toxicology. Boca Raton, FL: ...
  • Ettlinger R, Lachelt U, Gref R, Horcajada P, Lammers T, ...
  • Wu P, Lin S, Cao G, Wu J, Jin H, ...
  • Zhao Y, Zhang L, Shen J, Ma L, Wang L. ...
  • Stanfield Z, Setzer RW, Hull V, Sayre RR, Isaacs KK, ...
  • Deepika D, Kumar V. The role of "Physiologically Based Pharmacokinetic ...
  • Pantic I, Paunovic J, Cumic J, Valjarevic S, Petroianu GA, ...
  • Ciallella HL, Russo DP, Sharma S, Li Y, Sloter E, ...
  • Edginton AN, Theil FP, Schmitt W, Willmann S. Whole body ...
  • El-Khateeb E, Burkhill S, Murby S, Amirat H, Rostami-Hodjegan A, ...
  • East A, Dawson DE, Brady S, Vallero DA, Tornero-Velez R. ...
  • Savva, M. On the origin of the apparent volume of ...
  • Sung JH, Srinivasan B, Esch MB, McLamb WT, Bernabini C, ...
  • Di Toro DM, McGrath JA, Stubblefield WA. Predicting the toxicity ...
  • Martin O, Scholze M, Ermler S, McPhie J, Bopp SK, ...
  • Barber MC. Dietary uptake models used for modeling the bioaccumulation ...
  • Schlattmann P. Medical applications of finite mixture models. Berlin Heidelberg, ...
  • Li M, Al-Jamal KT, Kostarelos K, Reineke J. Physiologically based ...
  • Andersen ME. Toxicokinetic modeling and its applications in chemical risk ...
  • Kolli AR, Kuczaj AK, Martin F, Hayes AW, Peitsch MC, ...
  • Haggard HW. The absorption, distribution, and elimination of ethyl ether: ...
  • Cohen YVES. Radionuclide-labelled compounds in the approach of pharmacokinetics related ...
  • Mounter LA. The specificity of cobra-venom cholinesterase. Biochem J ۱۹۵۱; ...
  • Holaday DA, Fiserova-Bergerova V, Latto IP, Zumbiel MA. Resistance of ...
  • Ramoju S, Andersen ME, Nong A, Karyakina N, Shilnikova N, ...
  • Valcke M, Krishnan K. Physiologically based pharmacokinetic modeling in the ...
  • Valcke M, Krishnan K. Physiologically based pharmacokinetic modeling in the ...
  • Sugita O, Sawada Y, Sugiyama Y, Iga T, Hanano M. ...
  • Purcell KJ, Cason GH, Gargas ML, Andersen ME, Travis CC. ...
  • Himmelstein MW, Turner MJ, Asgharian B, Bond JA. Comparison of ...
  • Tardif R, Lapare S, Krishnan K, Brodeur J. Physiologically based ...
  • Yu X, Johanson G, Ichihara G, Shibata E, Kamijima M, ...
  • Draper WM. Biological monitoring: exquisite research probes, risk assessment, and ...
  • Hack CE, Efremenko AY, Pendse SN, Ellison CA, Najjar A, ...
  • Chiu WA, Barton HA, DeWoskin RS, Schlosser P, Thompson CM, ...
  • Lin Z, Gehring R, Mochel JP, Lave T, Riviere JE. ...
  • Andersen ME, Yang RSH, Clewell HJ ۳rd, Reddy MB. Introduction: ...
  • Rostami-Hodjegan A. Physiologically based pharmacokinetics joined with in vitro-in vivo ...
  • Caldwell JC, Evans MV, Krishnan K. Cutting edge PBPK models ...
  • Krishnan K, Loizou GD, Spendiff M, Lipscomb JC, Andersen ME. ...
  • Sreedhar D, N. M, Pise A, Pise S, Ligade V. ...
  • Fentem J, Malcomber I, Maxwell G, Westmoreland C. Upholding the ...
  • Verner MA, Charbonneau M, Lopez-Carrillo L, Haddad S. Physiologically based ...
  • Lo Piparo E, Worth A. Review of QSAR Models and ...
  • Sanderson DM, Earnshaw CG. Computer prediction of possible toxic action ...
  • Venkatapathy R, Moudgal CJ, Bruce RM. Assessment of the oral ...
  • Lagunin A, Zakharov A, Filimonov D, Poroikov V. QSAR Modelling ...
  • Lagunin A, Stepanchikova A, Filimonov D, Poroikov V. PASS: Prediction ...
  • Uddayasankar U, Lee C, Oleschuk C, Eschun G, Ariano RE. ...
  • Lin Z, Jaberi-Douraki M, He C, Jin S, Yang RSH, ...
  • Sánchez G. Biokmod Applied To Evaluate Bioassay Data. Proceedings of ...
  • Bourne DW. BOOMER, a simulation and modeling program for pharmacokinetic ...
  • Chernykh I, Stoyanovskaya O, Zasypkina O. ChemPAK software package as ...
  • Vanjari S, Chimandare N, Gandhi S. A review on in ...
  • Steinmetz FP, Mellor CL, Meinl T, Cronin MT. Screening chemicals ...
  • Bolger MB. Cyber Patient (TM): A multimedia pharmacokinetic simulation program ...
  • Born B. Development of a new population pharmacokinetic model for ...
  • Arafat M, Sarfraz M, AbuRuz S. Development and in vitro ...
  • Pearce RG, Setzer RW, Strope CL, Wambaugh JF, Sipes NS. ...
  • Fragki S, Piersma AH, Westerhout J, Kienhuis A, Kramer NI, ...
  • Sakore S, Chakraborty B (۲۰۱۱) In Vitro-In Vivo Correlation (IVIVC): ...
  • Cheng YH, Chou WC, Yang YF, Huang CW, How CM, ...
  • Gabrielsson J, Andersson K, Tobin G, Ingvast-Larsson C, Jirstrand M. ...
  • Tsiros P, Bois FY, Dokoumetzidis A, Tsiliki G, Sarimveis H. ...
  • Ciffroy P, Alfonso B, Altenpohl A, Banjac Z, Bierkens J, ...
  • Henningsson Br. Preclinical PK/PD Models of tumor response in oncological ...
  • Foissac F, Treluyer JM, Souberbielle JC, Rostane H, Urien S, ...
  • Rousseau A, Leger F, Le MY, Saint-Marcoux F, Paintaud G, ...
  • Abouir K, Samer CF, Gloor Y, Desmeules JA, Daali Y. ...
  • Mukherjee B. Pharmacokinetic software and tools. In: Mukherjee B, editor. ...
  • Shah A. Pharmacokinetic Modeling Program (PKMP): A software for PK/PD ...
  • Farenc C, Fabreguette JR, Bressolle F. Pk-fit: A pharmacokinetic/pharmacodynamic and ...
  • Yilmaz B, Terekeci H, Sandal S, Kelestimur F. Endocrine disrupting ...
  • Timbrell J, Barile FA. Introduction to toxicology. Boca Raton, FL: ...
  • Ettlinger R, Lachelt U, Gref R, Horcajada P, Lammers T, ...
  • Wu P, Lin S, Cao G, Wu J, Jin H, ...
  • Zhao Y, Zhang L, Shen J, Ma L, Wang L. ...
  • Stanfield Z, Setzer RW, Hull V, Sayre RR, Isaacs KK, ...
  • Deepika D, Kumar V. The role of "Physiologically Based Pharmacokinetic ...
  • Pantic I, Paunovic J, Cumic J, Valjarevic S, Petroianu GA, ...
  • Ciallella HL, Russo DP, Sharma S, Li Y, Sloter E, ...
  • Edginton AN, Theil FP, Schmitt W, Willmann S. Whole body ...
  • El-Khateeb E, Burkhill S, Murby S, Amirat H, Rostami-Hodjegan A, ...
  • East A, Dawson DE, Brady S, Vallero DA, Tornero-Velez R. ...
  • Savva, M. On the origin of the apparent volume of ...
  • Sung JH, Srinivasan B, Esch MB, McLamb WT, Bernabini C, ...
  • Di Toro DM, McGrath JA, Stubblefield WA. Predicting the toxicity ...
  • Martin O, Scholze M, Ermler S, McPhie J, Bopp SK, ...
  • Barber MC. Dietary uptake models used for modeling the bioaccumulation ...
  • Schlattmann P. Medical applications of finite mixture models. Berlin Heidelberg, ...
  • Li M, Al-Jamal KT, Kostarelos K, Reineke J. Physiologically based ...
  • Andersen ME. Toxicokinetic modeling and its applications in chemical risk ...
  • Kolli AR, Kuczaj AK, Martin F, Hayes AW, Peitsch MC, ...
  • Haggard HW. The absorption, distribution, and elimination of ethyl ether: ...
  • Cohen YVES. Radionuclide-labelled compounds in the approach of pharmacokinetics related ...
  • Mounter LA. The specificity of cobra-venom cholinesterase. Biochem J ۱۹۵۱; ...
  • Holaday DA, Fiserova-Bergerova V, Latto IP, Zumbiel MA. Resistance of ...
  • Ramoju S, Andersen ME, Nong A, Karyakina N, Shilnikova N, ...
  • Valcke M, Krishnan K. Physiologically based pharmacokinetic modeling in the ...
  • Valcke M, Krishnan K. Physiologically based pharmacokinetic modeling in the ...
  • Sugita O, Sawada Y, Sugiyama Y, Iga T, Hanano M. ...
  • Purcell KJ, Cason GH, Gargas ML, Andersen ME, Travis CC. ...
  • Himmelstein MW, Turner MJ, Asgharian B, Bond JA. Comparison of ...
  • Tardif R, Lapare S, Krishnan K, Brodeur J. Physiologically based ...
  • Yu X, Johanson G, Ichihara G, Shibata E, Kamijima M, ...
  • Draper WM. Biological monitoring: exquisite research probes, risk assessment, and ...
  • Hack CE, Efremenko AY, Pendse SN, Ellison CA, Najjar A, ...
  • Chiu WA, Barton HA, DeWoskin RS, Schlosser P, Thompson CM, ...
  • Lin Z, Gehring R, Mochel JP, Lave T, Riviere JE. ...
  • Andersen ME, Yang RSH, Clewell HJ ۳rd, Reddy MB. Introduction: ...
  • Rostami-Hodjegan A. Physiologically based pharmacokinetics joined with in vitro-in vivo ...
  • Caldwell JC, Evans MV, Krishnan K. Cutting edge PBPK models ...
  • Krishnan K, Loizou GD, Spendiff M, Lipscomb JC, Andersen ME. ...
  • Sreedhar D, N. M, Pise A, Pise S, Ligade V. ...
  • Fentem J, Malcomber I, Maxwell G, Westmoreland C. Upholding the ...
  • Verner MA, Charbonneau M, Lopez-Carrillo L, Haddad S. Physiologically based ...
  • Lo Piparo E, Worth A. Review of QSAR Models and ...
  • Sanderson DM, Earnshaw CG. Computer prediction of possible toxic action ...
  • Venkatapathy R, Moudgal CJ, Bruce RM. Assessment of the oral ...
  • Lagunin A, Zakharov A, Filimonov D, Poroikov V. QSAR Modelling ...
  • Lagunin A, Stepanchikova A, Filimonov D, Poroikov V. PASS: Prediction ...
  • Uddayasankar U, Lee C, Oleschuk C, Eschun G, Ariano RE. ...
  • Lin Z, Jaberi-Douraki M, He C, Jin S, Yang RSH, ...
  • Sánchez G. Biokmod Applied To Evaluate Bioassay Data. Proceedings of ...
  • Bourne DW. BOOMER, a simulation and modeling program for pharmacokinetic ...
  • Chernykh I, Stoyanovskaya O, Zasypkina O. ChemPAK software package as ...
  • Vanjari S, Chimandare N, Gandhi S. A review on in ...
  • Steinmetz FP, Mellor CL, Meinl T, Cronin MT. Screening chemicals ...
  • Bolger MB. Cyber Patient (TM): A multimedia pharmacokinetic simulation program ...
  • Born B. Development of a new population pharmacokinetic model for ...
  • Arafat M, Sarfraz M, AbuRuz S. Development and in vitro ...
  • Pearce RG, Setzer RW, Strope CL, Wambaugh JF, Sipes NS. ...
  • Fragki S, Piersma AH, Westerhout J, Kienhuis A, Kramer NI, ...
  • Sakore S, Chakraborty B (۲۰۱۱) In Vitro-In Vivo Correlation (IVIVC): ...
  • Cheng YH, Chou WC, Yang YF, Huang CW, How CM, ...
  • Gabrielsson J, Andersson K, Tobin G, Ingvast-Larsson C, Jirstrand M. ...
  • Tsiros P, Bois FY, Dokoumetzidis A, Tsiliki G, Sarimveis H. ...
  • Ciffroy P, Alfonso B, Altenpohl A, Banjac Z, Bierkens J, ...
  • Henningsson Br. Preclinical PK/PD Models of tumor response in oncological ...
  • Foissac F, Treluyer JM, Souberbielle JC, Rostane H, Urien S, ...
  • Rousseau A, Leger F, Le MY, Saint-Marcoux F, Paintaud G, ...
  • Abouir K, Samer CF, Gloor Y, Desmeules JA, Daali Y. ...
  • Mukherjee B. Pharmacokinetic software and tools. In: Mukherjee B, editor. ...
  • Shah A. Pharmacokinetic Modeling Program (PKMP): A software for PK/PD ...
  • Farenc C, Fabreguette JR, Bressolle F. Pk-fit: A pharmacokinetic/pharmacodynamic and ...
  • نمایش کامل مراجع